Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

HIV infection and coronary heart disease: an intersection of epidemics.

Triant VA.

J Infect Dis. 2012 Jun;205 Suppl 3:S355-61. doi: 10.1093/infdis/jis195. Review.

2.
3.

Does antiretroviral therapy increase or decrease the risk of cardiovascular disease?

Fichtenbaum CJ.

Curr HIV/AIDS Rep. 2010 May;7(2):92-8. doi: 10.1007/s11904-010-0045-5. Review.

PMID:
20425563
4.

Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution.

Hadigan C, Meigs JB, Wilson PW, D'Agostino RB, Davis B, Basgoz N, Sax PE, Grinspoon S.

Clin Infect Dis. 2003 Apr 1;36(7):909-16. Epub 2003 Mar 20.

5.

Coronary heart disease in HIV-infected individuals.

Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S.

J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):506-12.

PMID:
12869840
6.

Cardiovascular risk and dyslipidemia management in HIV-infected patients.

Stein JH.

Top Antivir Med. 2012 Oct-Nov;20(4):129-33; quiz 123-4. Review.

7.

Risk of coronary heart disease in patients with HIV infection.

Zanni MV, Schouten J, Grinspoon SK, Reiss P.

Nat Rev Cardiol. 2014 Dec;11(12):728-41. doi: 10.1038/nrcardio.2014.167. Epub 2014 Oct 21. Review.

PMID:
25331088
8.

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

Circulation. 2009 Feb 17;119(6):805-11. doi: 10.1161/CIRCULATIONAHA.108.790857. Epub 2009 Feb 2.

9.

Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy.

Bucher HC, Rickenbach M, Young J, Glass TR, Vallet Y, Bernasconi E, Cavassini M, Fux C, Schiffer V, Vernazza P, Weber R, Battegay M; Swiss HIV Cohort Study.

Antivir Ther. 2010;15(1):31-40. doi: 10.3851/IMP1475.

PMID:
20167989
10.

Fenofibrate in the treatment of dyslipidemia associated with HIV infection.

Samineni D, Fichtenbaum CJ.

Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):995-1004. doi: 10.1517/17425255.2010.504715. Review.

PMID:
20604734
11.

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Klein D, Hurley LB, Quesenberry CP Jr, Sidney S.

J Acquir Immune Defic Syndr. 2002 Aug 15;30(5):471-7.

PMID:
12154337
12.

A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.

May M, Sterne JA, Shipley M, Brunner E, d'Agostino R, Whincup P, Ben-Shlomo Y, Carr A, Ledergerber B, Lundgren JD, Phillips AN, Massaro J, Egger M.

Int J Epidemiol. 2007 Dec;36(6):1309-18. Epub 2007 Jul 25.

13.

Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.

De Lorenzo F, Collot-Teixeira S, Boffito M, Feher M, Gazzard B, McGregor JL.

Curr Med Chem. 2008;15(28):2991-9. Review.

PMID:
19075647
14.

Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults.

Pullinger CR, Aouizerat BE, Gay C, Coggins T, Movsesyan I, Davis H, Kane JP, Portillo C, Lee KA.

Metab Syndr Relat Disord. 2010 Jun;8(3):279-86. doi: 10.1089/met.2009.0094.

15.

Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review.

Duong M, Buisson M, Cottin Y, Piroth L, Lhuillier I, Grappin M, Chavanet P, Wolff JE, Portier H.

Clin Cardiol. 2001 Oct;24(10):690-4. Review.

16.

Coronary heart disease in HIV-infected patients.

Glesby MJ.

Curr HIV/AIDS Rep. 2005 Jun;2(2):68-73. Review.

PMID:
16091251
17.
18.

Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries.

Lang S, Boccara F, Mary-Krause M, Cohen A.

Arch Cardiovasc Dis. 2015 Mar;108(3):206-15. doi: 10.1016/j.acvd.2015.01.004. Epub 2015 Feb 26. Review.

19.

Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study.

Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Mostardt S, Neumann A, Brockmeyer NH, Gelbrich G, Erbel R, Neumann T; German Competence Network Heart Failure; German Competence Network for HIV/AIDS.

Eur J Prev Cardiol. 2012 Apr;19(2):267-74. doi: 10.1177/1741826711398431. Epub 2011 Feb 28.

PMID:
21450595
20.

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.

Savès M, Chêne G, Ducimetière P, Leport C, Le Moal G, Amouyel P, Arveiler D, Ruidavets JB, Reynes J, Bingham A, Raffi F; French WHO MONICA Project and the APROCO (ANRS EP11) Study Group.

Clin Infect Dis. 2003 Jul 15;37(2):292-8. Epub 2003 Jul 7.

Items per page

Supplemental Content

Write to the Help Desk